Cingulate Inc. Warrants share price logo

Cingulate Inc. Warrants

NASDAQ: CINGW

$0.01

+0.00

(+14.94%)

Live

as on

Cingulate Inc. Warrants Stock Performance

as on October 24, 2026 at 12:35 am IST

  • $0.01
    $0.01

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Cingulate Inc. Warrants share price movements today

Previous Close
$0.01
Open
$0.01
Volume
1.5M
Day's Low - High
$0.01 - $0.01

Cingulate Inc. Warrants Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Cingulate Inc. Warrants Stock Fundamentals & Key Indicators

Check Cingulate Inc. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

Return On Equity TTM

-198.74%

Cingulate Inc. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Cingulate Inc. Warrants with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Cingulate Inc. Warrants image
Cingulate Inc. Warrants
NA$-NANA0.00%0.00%

Indian Investors' Interest in Cingulate Inc. Warrants Stock

Search interest for Cingulate Inc. Warrants Stock has decreased by -75% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-75% versus previous 30 day period

Cingulate Inc. Warrants Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-3,849
-
-
12,982
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-2
-3
-3
-6
-3
-4
-5
-5
-7
-5
EBITDA
-2
-3
-3
-6
-3
-4
-5
-5
-7
-5
Interest Expense
408
0
50
0
96
138
573
1
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-3
-4
-6
-3
-4
-7
-6
-9
-5
Income Tax Expense
0
-
-
-
-
-
-
-
-
-
Net Income
-2
-3
-4
-6
-3
-4
-7
-6
-9
-5
Net Profit Margin
0.08%
0.00%
0.00%
-0.05%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc. Warrants Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
Operating Income
-11
-7
-20
-17
-22
-15
-19
EBITDA
-11
-6
-19
-17
-22
-14
-19
Interest Expense
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-11
-7
-20
-17
-23
-16
-22
Income Tax Expense
0
0
0
0
0
0
-
Net Income
-11
-7
-20
-17
-23
-16
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Cingulate Inc. Warrants Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-3
-6
-3
-4
-7
-6
-9
-5
Operating Cash Flow
-1
-3
-4
-4
-4
-4
-3
-6
-5
Investing Cash Flow
0
0
0
-
0
-
0
0
0
Financing Cash Flow
1
13
6
1
4
1
8
21
8
Change in Cash
0
9
2
-2
0
-2
4
14
2

Cingulate Inc. Warrants Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-7
-20
-17
-23
-15
-22
Operating Cash Flow
-6
-10
-15
-15
-18
-17
Investing Cash Flow
0
0
0
0
0
0
Financing Cash Flow
7
26
4
9
30
16
Change in Cash
0
15
-11
-5
12
-1

About Cingulate Inc. Warrants

Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops CTx-2103 (buspirone), which is in a formulation stage for the treatment of anxiety. In addition, the company plans to initiate a clinical plan for CTx-1302 (dextroamphetamine) to treat ADHD. Cingulate Inc. was founded in 2012 and is headquartered in Kansas City, Kansas.
OrganisationCingulate Inc. Warrants
Headquarters1901 West 47th Place, Kansas City, KS, United States, 66205
IndustryHealth Care
CEODr. Shane J. Schaffer Pharm.D.

Key Management of Cingulate Inc. Warrants

Name

Title

Dr. Shane J. Schaffer Pharm.D.

Co-Founder, CEO & Chairman of the Board

Dr. Matthew N. Brams M.D.

Co-Founder, Executive VP & Chief Medical Officer

Ms. Jennifer L. Callahan CPA

Executive VP, CFO & Secretary

Dr. Raul R. Silva M.D.

Co-Founder, Executive VP & Chief Science Officer

Mr. Thomas Dalton

Vice President of Investor & Public Relations

Mr. Downey Bryan Wade

Executive VP & Chief Commercial Officer

FAQs

What is Cingulate Inc. Warrants share price today?

Cingulate Inc. Warrants share price today is $0.01 as on . Cingulate Inc. Warrants share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for Cingulate Inc. Warrants share?

Cingulate Inc. Warrants share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Cingulate Inc. Warrants stock price today i.e. is trending at $0.01,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in Cingulate Inc. Warrants Stock (CINGW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cingulate Inc. Warrants on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Cingulate Inc. Warrants Stock (CINGW) from India?

Indian investors can start investing in Cingulate Inc. Warrants (CINGW) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Cingulate Inc. Warrants stock (as per the Rupee-Dollar exchange rate as on ). Based on Cingulate Inc. Warrants share’s latest price of $0.01 as on October 23, 2026 at 7:05 pm IST, you will get 1000.0000 shares of Cingulate Inc. Warrants. Learn more about fractional shares .